Pain and functional outcomes of the sacroiliac joint after platelet-rich plasma injection : a descriptive review
The purpose of this manuscript is to highlight and review the status of literature regarding efficacy of platelet-rich plasma (PRP) in the treatment of sacroiliac joint (SIJ) dysfunction. A review of the literature on PRP interventions on the SIJ or ligaments was performed. Seven studies had improvements in their respective primary end point and demonstrated a strong safety profile without any serious adverse events. Only five articles demonstrated clinical efficacy of >50% in their primary outcome measures. There appears to be inconsistent and insufficient evidence for a conclusive recommendation for or against SIJ PRP. There is a need for adequately powered well-designed, standardized, double-blinded randomized clinical trials to determine the effectiveness of PRP in SIJ-mediated pain.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Regenerative medicine - 16(2021), 1 vom: 17. Jan., Seite 87-100 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rothenberg, Joshua B [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bone and cartilage |
---|
Anmerkungen: |
Date Completed 28.10.2021 Date Revised 28.10.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.2217/rme-2020-0110 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320944948 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320944948 | ||
003 | DE-627 | ||
005 | 20231225174746.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2217/rme-2020-0110 |2 doi | |
028 | 5 | 2 | |a pubmed24n1069.xml |
035 | |a (DE-627)NLM320944948 | ||
035 | |a (NLM)33533657 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rothenberg, Joshua B |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pain and functional outcomes of the sacroiliac joint after platelet-rich plasma injection |b a descriptive review |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.10.2021 | ||
500 | |a Date Revised 28.10.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The purpose of this manuscript is to highlight and review the status of literature regarding efficacy of platelet-rich plasma (PRP) in the treatment of sacroiliac joint (SIJ) dysfunction. A review of the literature on PRP interventions on the SIJ or ligaments was performed. Seven studies had improvements in their respective primary end point and demonstrated a strong safety profile without any serious adverse events. Only five articles demonstrated clinical efficacy of >50% in their primary outcome measures. There appears to be inconsistent and insufficient evidence for a conclusive recommendation for or against SIJ PRP. There is a need for adequately powered well-designed, standardized, double-blinded randomized clinical trials to determine the effectiveness of PRP in SIJ-mediated pain | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a bone and cartilage | |
650 | 4 | |a chronic pain | |
650 | 4 | |a hip pain | |
650 | 4 | |a low back pain | |
650 | 4 | |a musculoskeletal and joint disorders | |
650 | 4 | |a orthopaedics | |
650 | 4 | |a platelet-rich plasma | |
650 | 4 | |a regenerative medicine | |
650 | 4 | |a sacroiliac joint | |
650 | 4 | |a sports medicine | |
700 | 1 | |a Godha, Keshav |e verfasserin |4 aut | |
700 | 1 | |a Civitarese, David M |e verfasserin |4 aut | |
700 | 1 | |a Malanga, Gerard |e verfasserin |4 aut | |
700 | 1 | |a Singh, Jaspal Ricky |e verfasserin |4 aut | |
700 | 1 | |a Panero, Alberto |e verfasserin |4 aut | |
700 | 1 | |a Everts, Peter |e verfasserin |4 aut | |
700 | 1 | |a Dididze, Marine |e verfasserin |4 aut | |
700 | 1 | |a Jayaram, Prathap |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Regenerative medicine |d 2006 |g 16(2021), 1 vom: 17. Jan., Seite 87-100 |w (DE-627)NLM169957144 |x 1746-076X |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2021 |g number:1 |g day:17 |g month:01 |g pages:87-100 |
856 | 4 | 0 | |u http://dx.doi.org/10.2217/rme-2020-0110 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2021 |e 1 |b 17 |c 01 |h 87-100 |